1. Home
  2. CNTA vs SHO Comparison

CNTA vs SHO Comparison

Compare CNTA & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • SHO
  • Stock Information
  • Founded
  • CNTA 2020
  • SHO 1995
  • Country
  • CNTA United Kingdom
  • SHO United States
  • Employees
  • CNTA N/A
  • SHO N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • SHO Hotels/Resorts
  • Sector
  • CNTA Health Care
  • SHO Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • SHO Nasdaq
  • Market Cap
  • CNTA 2.2B
  • SHO 2.3B
  • IPO Year
  • CNTA 2021
  • SHO 1995
  • Fundamental
  • Price
  • CNTA $16.63
  • SHO $10.65
  • Analyst Decision
  • CNTA Strong Buy
  • SHO Hold
  • Analyst Count
  • CNTA 8
  • SHO 7
  • Target Price
  • CNTA $23.00
  • SHO $11.71
  • AVG Volume (30 Days)
  • CNTA 964.8K
  • SHO 1.7M
  • Earning Date
  • CNTA 03-27-2025
  • SHO 02-21-2025
  • Dividend Yield
  • CNTA N/A
  • SHO 3.36%
  • EPS Growth
  • CNTA N/A
  • SHO N/A
  • EPS
  • CNTA N/A
  • SHO 0.14
  • Revenue
  • CNTA $6,853,000.00
  • SHO $905,809,000.00
  • Revenue This Year
  • CNTA N/A
  • SHO N/A
  • Revenue Next Year
  • CNTA N/A
  • SHO $9.47
  • P/E Ratio
  • CNTA N/A
  • SHO $77.14
  • Revenue Growth
  • CNTA N/A
  • SHO N/A
  • 52 Week Low
  • CNTA $7.75
  • SHO $9.39
  • 52 Week High
  • CNTA $19.09
  • SHO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 48.19
  • SHO 32.72
  • Support Level
  • CNTA $15.50
  • SHO $10.99
  • Resistance Level
  • CNTA $18.55
  • SHO $11.51
  • Average True Range (ATR)
  • CNTA 1.25
  • SHO 0.26
  • MACD
  • CNTA -0.12
  • SHO -0.02
  • Stochastic Oscillator
  • CNTA 31.57
  • SHO 3.37

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. Sunstone's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: